Successful kidney transplantation after significant improvement of left ventricular function with guideline-directed medical therapy including angiotensin receptor-neprilysin inhibitor and beta blocker in a hemodialysis patient: a case report
Abstract Background Although angiotensin receptor-neprilysin inhibitor (ARNI; sacubitril/valsartan) is a well-established treatment for heart failure with reduced ejection fraction (HFrEF), evidence of its efficacy in hemodialysis (HD) patients remains limited. Case presentation We present the case...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2025-10-01
|
| Serija: | Renal Replacement Therapy |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s41100-025-00670-3 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
